50242-130 : Alecensa 150 mg Oral Capsule
| NDC: | 50242-130 |
| Labeler: | Genentech, Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Alecensa |
| Dosage Form: | Oral Capsule |
| Application #: | NDA208434 |
| Rev. Date: |
Appearance:
| Markings: | ALE;150;mg |
| Shapes: |
Capsule |
| Colors: |
 White |
| Size (mm): | 19 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
NDC Package Codes:
- 50242-130-01: 1 BOTTLE, PLASTIC IN 1 CARTON (50242‑130‑01) > 240 CAPSULE IN 1 BOTTLE, PLASTIC
- 50242-130-86: 1 BOTTLE, PLASTIC IN 1 CARTON (50242‑130‑86) > 240 CAPSULE IN 1 BOTTLE, PLASTIC
Active Ingredients:
- Alectinib Hydrochloride
Dosage Strength:
- 150 mg
Inactive Ingredients:
- Carrageenan
- Potassium Chloride
- Titanium Dioxide
- Carnauba Wax
- Starch, Corn
- Hypromelloses
- Ferric Oxide Red
- Ferric Oxide Yellow
- Fd&c Blue No. 2
- Aluminum Oxide
- Shellac
- Glyceryl Oleate
Pharmaceutical Classes:
- Kinase Inhibitor [EPC]
- Kinase Inhibitors [MoA]
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 50242-127Next: 50242-132 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.